BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eriksson M, Käyhty H, Saha H, Lahdenkari M, Koskinen P, Mäkisalo H, Anttila VJ. A randomized, controlled trial comparing the immunogenecity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients. Transpl Infect Dis 2020;22:e13343. [PMID: 32473046 DOI: 10.1111/tid.13343] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Blanchard-Rohner G, Enriquez N, Lemaître B, Cadau G, Giostra E, Hadaya K, Meyer P, Gasche-Soccal PM, Berney T, van Delden C, Siegrist CA. Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipients. Vaccine 2021;39:3459-66. [PMID: 34023135 DOI: 10.1016/j.vaccine.2021.05.030] [Reference Citation Analysis]
2 Ryu H, Narayanan N, Bhatt PJ. Prevention of infection and optimizing vaccination in the solid organ transplant candidate and recipient. Curr Opin Organ Transplant 2021;26:445-55. [PMID: 34227584 DOI: 10.1097/MOT.0000000000000902] [Reference Citation Analysis]
3 Eriksson M, Käyhty H, Lahdenkari M, Mäkisalo H, Anttila VJ. A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients. Vaccine 2021;39:2351-9. [PMID: 33812743 DOI: 10.1016/j.vaccine.2021.03.063] [Reference Citation Analysis]
4 Gidengil C, Goetz MB, Newberry S, Maglione M, Hall O, Larkin J, Motala A, Hempel S. Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis. Vaccine 2021;39:3696-716. [PMID: 34049735 DOI: 10.1016/j.vaccine.2021.03.079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Dawson RS, Feemster K, McIntosh EDG, Buchwald UK. Response to Eriksson et al A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients. Transpl Infect Dis 2021;23:e13493. [PMID: 33047468 DOI: 10.1111/tid.13493] [Reference Citation Analysis]